Macrophages and chemokines as mediators of angiogenesis

Frontiers in Physiology

Volumn 4 JUL, Issue , 2013, Pages

  Owen, Jennifer L ^a   Mohamadzadeh, Mansour ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Chemokine receptors; Chemokines; Macrophages; Tumor associated macrophages; Tumors

Indexed keywords

ALPHA CHEMOKINE; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ARGININE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FRACTALKINE; GLUTAMIC ACID; LEUCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; CARCINOGENESIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE PRODUCTION; EMBRYO DEVELOPMENT; HUMAN; MACROPHAGE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VASCULARIZATION;

EID: 84884563645     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00159     Document Type: Review

References (86)

1. Ahn, G. O., and Brown, J. M. (2009). Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. Angiogenesis 12, 159-164. doi: 10.1007/s10456-009-9135-7
2. Airoldi, I., and Ribatti, D. (2011). Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors. J. Leukoc. Biol. 90, 875-882. doi: 10.1189/jlb.0511237
3. Allavena, P., Germano, G., Marchesi, F., and Mantovani, A. (2011). Chemokines in cancer related inflammation. Exp. Cell Res. 317, 664-673. doi: 10.1016/j.yexcr.2010.11.013
4. Asahara, T., Kawamoto, A., and Masuda, H. (2011). Concise review: circulating endothelial progenitor cells for vascular medicine. Stem cells 29, 1650-1655. doi: 10.1002/stem.745
5. Asahara, T., Murohara, T., Sullivan, A., Silver, M., Van Der Zee, R., Li, T., and et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967. doi: 10.1126/science.275.5302.964
6. Baay, M., Brouwer, A., Pauwels, P., Peeters, M., and Lardon, F. (2011). Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin. Dev. Immunol. 2011:565187. doi: 10.1155/2011/565187
7. Balkwill, F. (2004). The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171-179. doi: 10.1016/j.semcancer.2003.10.003
8. Ben-Baruch, A. (2012). The tumor-promoting flow of cells into, within and out of the tumor site: regulation by the inflammatory axis of TNFα and Chemokines. Cancer Microenviron. 5, 151-164. doi: 10.1007/s12307-011-0094-3
9. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., and et al. (2007). MIF is a non-cognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596. doi: 10.1038/nm1567
10. Bingle, L., Brown, N. J., and Lewis, C. E. (2002). The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265. doi: 10.1002/path.1027
11. Bosco, M. C., Reffo, G., Puppo, M., and Varesio, L. (2004). Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. Cell. Immunol. 228, 1-7. doi: 10.1016/j.cellimm.2004.03.006
12. Bussolati, B., Grange, C., and Camussi, G. (2011). Tumor exploits alternative strategies to achieve vascularization. FASEB J. 25, 2874-2882. doi: 10.1096/fj.10-180323
13. Claesson-Welsh, L., and Welsh, M. (2013). VEGFA and tumour angiogenesis. J. Int. Med. 273, 114-127. doi: 10.1111/joim.12019
14. Collins, C. B., Mcnamee, E. N., Wermers, J. D., Lebsack, M. D., and Rivera-Nieves, J. (2010). Chemokine decoy receptor D6 in inflammatory bowel disease (IBD) and IBD-associated colon cancer. Gut 59, 151-152. doi: 10.1136/gut.2009.192708
15. Craig, M. J., and Loberg, R. D. (2006). CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases. Cancer Metastasis Rev. 25, 611-619. doi: 10.1007/s10555-006-9027-x
16. De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L., and Lewis, C. E. (2007). Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28, 519-524. doi: 10.1016/j.it.2007.09.004
17. Domanska, U. M., Kruizinga, R. C., Nagengast, W. B., Timmer-Bosscha, H., Huls, G., De Vries, E. G., and et al. (2013). A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur. J. Cancer 49, 219-230. doi: 10.1016/j.ejca.2012.05.005
18. Dubrac, A., Quemener, C., Lacazette, E., Lopez, F., Zanibellato, C., Wu, W. G., and et al. (2010). Functional divergence between 2 chemokines is conferred by single amino acid change. Blood 116, 4703-4711. doi: 10.1182/blood-2010-03-274852
19. Egami, K., Murohara, T., Aoki, M., and Matsuishi, T. (2006). Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin. J. Leukoc. Biol. 79, 971-976. doi: 10.1189/jlb.0805448
20. Fagiani, E., and Christofori, G. (2013). Angiopoietins in angiogenesis. Cancer Lett. 328, 18-26. doi: 10.1016/j.canlet.2012.08.018
21. Fokas, E., Mckenna, W. G., and Muschel, R. J. (2012). The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies. Cancer Metastasis Rev. 31, 823-842. doi: 10.1007/s10555-012-9394-4
22. Gao, D., Nolan, D. J., Mellick, A. S., Bambino, K., Mcdonnell, K., and Mittal, V. (2008). Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319, 195-198. doi: 10.1126/science.1150224
23. Gijsbers, K., Gouwy, M., Struyf, S., Wuyts, A., Proost, P., Opdenakker, G., and et al. (2005). GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp. Cell Res. 303, 331-342. doi: 10.1016/j.yexcr.2004.09.027
24. Gomez, I., Pena, C., Herrera, M., Munoz, C., Larriba, M. J., Garcia, V., and et al. (2011). TWIST1 is expressed in colorectal carcinomas and predicts patient survival. PLoS ONE 6, e18023. doi: 10.1371/journal.pone.0018023
25. Gordon, S., and Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604. doi: 10.1016/j.immuni.2010.05.007
26. Halin, S., Rudolfsson, S. H., Van Rooijen, N., and Bergh, A. (2009). Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia 11, 177-186.
27. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013
28. Hao, N. B., Lu, M. H., Fan, Y. H., Cao, Y. L., Zhang, Z. R., and Yang, S. M. (2012). Macrophages in tumor microenvironments and the progression of tumors. Clin. Dev. Immunol. 2012, 948098. doi: 10.1155/2012/948098
29. Hernandez, L., Magalhaes, M. A., Coniglio, S. J., Condeelis, J. S., and Segall, J. E. (2011). Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res. 13, R128. doi: 10.1186/bcr3074
30. Islam, S. A., Chang, D. S., Colvin, R. A., Byrne, M. H., Mccully, M. L., Moser, B., and et al. (2011). Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat. Immunol. 12, 167-177. doi: 10.1038/ni.1984
31. Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., and et al. (2005). The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res. 65, 3200-3208. doi: 10.1158/0008-5472.CAN-04-3770
32. Keeley, E. C., Mehrad, B., and Strieter, R. M. (2011). Chemokines as mediators of tumor angiogenesis and neovascularization. Exp. Cell Res. 317, 685-690. doi: 10.1016/j.yexcr.2010.10.020
33. Kiefer, F., and Siekmann, A. F. (2011). The role of chemokines and their receptors in angiogenesis. Cell. Mol. Life Sci. 68, 2811-2830. doi: 10.1007/s00018-011-0677-7
34. Kumar, A. H., Martin, K., Turner, E. C., Buneker, C. K., Dorgham, K., Deterre, P., and et al. (2013). Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization. PLoS ONE 8:e57230. doi: 10.1371/journal.pone.0057230
35. Kumar, A. H., Metharom, P., Schmeckpeper, J., Weiss, S., Martin, K., and Caplice, N. M. (2010). Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J. 24, 81-92. doi: 10.1096/fj.09-132225
36. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., and et al. (2003). An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537-1549. doi: 10.1084/jem.20021897
37. Lee, H. W., Choi, H. J., Ha, S. J., Lee, K. T., and Kwon, Y. G. (2013). Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim. Biophys. Acta 1835, 170-179.
38. Lewis, C. E., and Pollard, J. W. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612. doi: 10.1158/0008-5472.CAN-05-4005
39. Liang, Z., Brooks, J., Willard, M., Liang, K., Yoon, Y., Kang, S., and et al. (2007). CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem. Biophys. Res. Commun. 359, 716-722. doi: 10.1016/j.bbrc.2007.05.182
40. Lin, E. Y., Li, J. F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., and et al. (2006). Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238-11246. doi: 10.1158/0008-5472.CAN-06-1278
41. Liu, G., and Yang, H. (2013). Modulation of macrophage activation and programming in immunity. J. Cell. Physiol. 228, 502-512. doi: 10.1002/jcp.24157
42. Low-Marchelli, J. M., Ardi, V. C., Vizcarra, E. A., Van Rooijen, N., Quigley, J. P., and Yang, J. (2013). Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res. 73, 662-671. doi: 10.1158/0008-5472.CAN-12-0653
43. Lu, J., Pompili, V. J., and Das, H. (2011). Neovascularization and Hematopoietic Stem Cells. Cell Biochem. Biophys. doi: 10.1007/s12013-011-9298-x. [Epub ahead of print].
44. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., and et al. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201. doi: 10.1038/nm1101-1194
45. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., and et al. (1990). Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79. doi: 10.1126/science.1688470
46. Mantovani, A., Savino, B., Locati, M., Zammataro, L., Allavena, P., and Bonecchi, R. (2010). The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 21, 27-39. doi: 10.1016/j.cytogfr.2009.11.007
47. Mantovani, A., and Sica, A. (2010). Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237. doi: 10.1016/j.coi.2010.01.009
48. Mantovani, A., Sica, A., Allavena, P., Garlanda, C., and Locati, M. (2009). Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 70, 325-330. doi: 10.1016/j.humimm.2009.02.008
49. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. doi: 10.1016/j.it.2004.09.015
50. Moepps, B., Nuesseler, E., Braun, M., and Gierschik, P. (2006). A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol. Immunol. 43, 897-914. doi: 10.1016/j.molimm.2005.06.043
51. Motz, G. T., and Coukos, G. (2011). The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat. Rev. Immunol. 11, 702-711. doi: 10.1038/nri3064
52. Mukaida, N., and Baba, T. (2012). Chemokines in tumor development and progression. Exp. Cell Res. 318, 95-102. doi: 10.1016/j.yexcr.2011.10.012
53. Murdoch, C., Muthana, M., Coffelt, S. B., and Lewis, C. E. (2008). The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8, 618-631. doi: 10.1038/nrc2444
54. Nagy, J. A., Chang, S. H., Shih, S. C., Dvorak, A. M., and Dvorak, H. F. (2010). Heterogeneity of the tumor vasculature. Semin. Thromb. Hemost. 36, 321-331. doi: 10.1055/s-0030-1253454
55. Nomiyama, H., Osada, N., and Yoshie, O. (2010). The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev. 21, 253-262. doi: 10.1016/j.cytogfr.2010.03.004
56. Nozawa, H., Chiu, C., and Hanahan, D. (2006). Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 103, 12493-12498. doi: 10.1073/pnas.0601807103
57. Petit, I., Jin, D., and Rafii, S. (2007). The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 28, 299-307. doi: 10.1016/j.it.2007.05.007
58. Purhonen, S., Palm, J., Rossi, D., Kaskenpaa, N., Rajantie, I., Yla-Herttuala, S., and et al. (2008). Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U.S.A. 105, 6620-6625. doi: 10.1073/pnas.0710516105
59. Qin, Q., Xu, Y., He, T., Qin, C., and Xu, J. (2012). Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 22, 90-106. doi: 10.1038/cr.2011.144
60. Raica, M., Cimpean, A. M., and Ribatti, D. (2009). Angiogenesis in pre-malignant conditions. Eur. J. Cancer 45, 1924-1934. doi: 10.1016/j.ejca.2009.04.007
61. Raman, D., Sobolik-Delmaire, T., and Richmond, A. (2011). Chemokines in health and disease. Exp. Cell Res. 317, 575-589. doi: 10.1016/j.yexcr.2011.01.005
62. Reed, J. R., Stone, M. D., Beadnell, T. C., Ryu, Y., Griffin, T. J., and Schwertfeger, K. L. (2012). Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner. PLoS ONE 7:e45877. doi: 10.1371/journal.pone.0045877
63. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674. doi: 10.1038/386671a0
64. Saederup, N., Chan, L., Lira, S. A., and Charo, I. F. (2008). Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis. Circulation 117, 1642-1648. doi: 10.1161/CIRCULATIONAHA.107.743872
65. Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., and et al. (2000). Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96, 34-40.
66. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., and et al. (2003). Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402. doi: 10.1084/jem.20030267
67. Sica, A., Saccani, A., Bottazzi, B., Bernasconi, S., Allavena, P., Gaetano, B., and et al. (2000). Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J. Immunol. 164, 733-738.
68. Simons, D., Grieb, G., Hristov, M., Pallua, N., Weber, C., Bernhagen, J., and et al. (2011). Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J. Cell. Mol. Med. 15, 668-678. doi: 10.1111/j.1582-4934.2010.01041.x
69. Singh, A. K., Arya, R. K., Trivedi, A. K., Sanyal, S., Baral, R., Dormond, O., and et al. (2013). Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Rev. 24, 41-49. doi: 10.1016/j.cytogfr.2012.08.007
70. Soria, G., and Ben-Baruch, A. (2008). The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271-285. doi: 10.1016/j.canlet.2008.03.018
71. Struyf, S., Salogni, L., Burdick, M. D., Vandercappellen, J., Gouwy, M., Noppen, S., and et al. (2011). Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. Blood 117, 480-488. doi: 10.1182/blood-2009-11-253591
72. Tazzyman, S., Niaz, H., and Murdoch, C. (2013). Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. Semin. Cancer Biol. 23, 149-158. doi: 10.1016/j.semcancer.2013.02.003
73. Teicher, B. A., and Fricker, S. P. (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res. 16, 2927-2931. doi: 10.1158/1078-0432.CCR-09-2329
74. Toulza, F., Eliaou, J. F., and Pinet, V. (2005). Breast tumor cell soluble factors induce monocytes to produce angiogenic but not angiostatic CXC chemokines. Int. J. Cancer 115, 429-436. doi: 10.1002/ijc.20705
75. Traves, P. G., Luque, A., and Hortelano, S. (2012). Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game. Mediators Inflamm. 2012:568783. doi: 10.1155/2012/568783
76. Vandercappellen, J., Van Damme, J., and Struyf, S. (2011). The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. Cytokine Growth Factor Rev. 22, 1-18. doi: 10.1016/j.cytogfr.2010.10.011
77. Verbeke, H., Struyf, S., Laureys, G., and Van Damme, J. (2011). The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev. 22, 345-358. doi: 10.1016/j.cytogfr.2011.09.002
78. White, G. E., and Greaves, D. R. (2009). Fractalkine: one chemokine, many functions. Blood 113, 767-768. doi: 10.1182/blood-2008-11-189860
79. Xu, L., Duda, D. G., Di Tomaso, E., Ancukiewicz, M., Chung, D. C., Lauwers, G. Y., and et al. (2009). Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res. 69, 7905-7910. doi: 10.1158/0008-5472.CAN-09-2099
80. Yamaguchi, K., Ogawa, K., Katsube, T., Shimao, K., Konno, S., Shimakawa, T., and et al. (2005). Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis. Anticancer Res. 25, 847-851.
81. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., and et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939. doi: 10.1016/j.cell.2004.06.006
82. Yoshimura, T., and Oppenheim, J. J. (2011). Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp. Cell Res. 317, 674-684. doi: 10.1016/j.yexcr.2010.10.023
83. Zhang, J., Patel, L., and Pienta, K. J. (2010). CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine Growth Factor Rev. 21, 41-48. doi: 10.1016/j.cytogfr.2009.11.009
84. Zlotnik, A., Burkhardt, A. M., and Homey, B. (2011). Homeostatic chemokine receptors and organ-specific metastasis. Nat. Rev. Immunol. 11, 597-606. doi: 10.1038/nri3049
85. Zlotnik, A., and Yoshie, O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127. doi: 10.1016/S1074-7613(00)80165-X
86. Zlotnik, A., and Yoshie, O. (2012). The chemokine superfamily revisited. Immunity 36, 705-716. doi: 10.1016/j.immuni.2012.05.008